The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1847 GOEDEKER INC | *W EXP 99/99/999 | 28252C117 | 11,569 | 6,886,600 | SH | SOLE | 6,886,600 | 0 | 0 | ||
ACHIEVE LIFE SCIENCES INC | COM | 004468500 | 1,037 | 122,000 | SH | SOLE | 122,000 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 3,071 | 625,469 | SH | SOLE | 625,469 | 0 | 0 | ||
ADICET BIO INC | COM | 007002108 | 1,116 | 142,289 | SH | SOLE | 142,289 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 4,847 | 609,689 | SH | SOLE | 609,689 | 0 | 0 | ||
AFFIMED N V | COM | N01045108 | 4,110 | 665,000 | SH | SOLE | 665,000 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 7,586 | 864,020 | SH | SOLE | 864,020 | 0 | 0 | ||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 519 | 33,492 | SH | SOLE | 33,492 | 0 | 0 | ||
ALLENA PHARMACEUTICALS | COM | 018119107 | 963 | 1,067,886 | SH | SOLE | 1,067,886 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 5,494 | 166,700 | SH | Put | SOLE | 166,700 | 0 | 0 | |
ARCTURUS THERAPEUTICS HLDGS | COM | 03969T109 | 3,822 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 6,092 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
ARYA SCIENCES ACQUISITN CORP | CLASS A ORD SHS | G31658100 | 1,005 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 3,187 | 144,000 | SH | SOLE | 144,000 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 4,318 | 440,589 | SH | SOLE | 440,589 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 5,542 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 996 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 10,983 | 1,788,789 | SH | SOLE | 1,788,789 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 3,826 | 92,000 | SH | SOLE | 92,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 3,703 | 79,000 | SH | SOLE | 79,000 | 0 | 0 | ||
CARDIFF ONCOLOGY INC | COM | 14147L108 | 2,324 | 348,888 | SH | SOLE | 348,888 | 0 | 0 | ||
CAREDX INC | COM | 14167L103 | 5,703 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
CASTLE BIOSCIENCES INC | COM | 14843C105 | 4,821 | 72,500 | SH | SOLE | 72,500 | 0 | 0 | ||
CELCUITY INC | COM | 15102K100 | 2,610 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 9,988 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 611 | 20,700 | SH | Put | SOLE | 20,700 | 0 | 0 | |
CERUS CORP | COM | 157085101 | 6,699 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
CHAVANT CAPITAL ACQUISITN CO | *W EXP 99/99/999 | G2058L111 | 72 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
CHAVANT CAPITAL ACQUISITN CO | ORDINARY SHARES | G2058L103 | 1,970 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 1,744 | 281,790 | SH | SOLE | 281,790 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 5,933 | 465,000 | SH | SOLE | 465,000 | 0 | 0 | ||
CITIC CAPITAL ACQUISITION CO | COM CL A | G21513109 | 1,109 | 111,200 | SH | SOLE | 111,200 | 0 | 0 | ||
COLISEUM ACQUISITION CORP | CLASS A ORD SHS | G2263T123 | 846 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
COLOMBIER ACQUISITION CORP | CL A | 19533H108 | 484 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
COLOMBIER ACQUISITION CORP | *W EXP 99/99/999 | 19533H116 | 9 | 16,666 | SH | SOLE | 16,666 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 4,063 | 193,000 | SH | SOLE | 193,000 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L601 | 9,773 | 3,313,000 | SH | SOLE | 3,313,000 | 0 | 0 | ||
CURIS INC | COM NEW | 231269200 | 6,491 | 829,000 | SH | SOLE | 829,000 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 6,279 | 1,233,642 | SH | SOLE | 1,233,642 | 0 | 0 | ||
DOUBLEDOWN INTERACTIVE CO LT | ADS | 25862B109 | 2,818 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 2,706 | 166,636 | SH | SOLE | 166,636 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 1,319 | 197,500 | SH | SOLE | 197,500 | 0 | 0 | ||
ELOXX PHARMACEUTICALS INC | COM | 29014R103 | 1,822 | 1,118,000 | SH | SOLE | 1,118,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 107 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 3,912 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 3,861 | 370,551 | SH | SOLE | 370,551 | 0 | 0 | ||
FAT BRANDS INC | *W EXP 07/16/202 | 30258N121 | 1,297 | 227,000 | SH | SOLE | 227,000 | 0 | 0 | ||
FIRSTMARK HORIZON ACQUISITIO | CL A COM | 33765Y101 | 980 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
FLUX PWR HLDGS INC | COM NEW | 344057302 | 2,652 | 521,972 | SH | SOLE | 521,972 | 0 | 0 | ||
FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 1,990 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
GALERA THERAPEUTICS INC | COM | 36338D108 | 2,435 | 300,605 | SH | SOLE | 300,605 | 0 | 0 | ||
GIGINTERNATIONAL1 INC | *W EXP 04/19/202 | 37518W114 | 37 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
GIGINTERNATIONAL1 INC | COM | 37518W106 | 1,974 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
GLOBUS MED INC | CL A | 379577208 | 2,950 | 38,500 | SH | SOLE | 38,500 | 0 | 0 | ||
HAEMONETICS CORP MASS | COM | 405024100 | 5,224 | 74,000 | SH | SOLE | 74,000 | 0 | 0 | ||
HARBOR CUSTOM DEVELOPMENT IN | *W EXP 05/09/202 | 41150T116 | 351 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 99 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
HEALTHCOR CATALIO ACQU CORP | CL A SHS | G44125105 | 1,980 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 2,488 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
HILLMAN SOLUTIONS CORP | COM | 431636109 | 1,694 | 142,000 | SH | SOLE | 142,000 | 0 | 0 | ||
ICAD INC | COM NEW | 44934S206 | 3,440 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
IGM BIOSCIENCES INC | COM | 449585108 | 2,793 | 42,473 | SH | SOLE | 42,473 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 4,056 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 389 | 97,467 | SH | SOLE | 97,467 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 6,227 | 478,987 | SH | SOLE | 478,987 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 5,600 | 203,354 | SH | SOLE | 203,354 | 0 | 0 | ||
INSPIRE MED SYS INC | COM | 457730109 | 6,055 | 26,000 | SH | SOLE | 26,000 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 1,208 | 4,250 | SH | SOLE | 4,250 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 5,328 | 328,101 | SH | SOLE | 328,101 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 1,950 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
KALEYRA INC | COM | 483379103 | 5,335 | 484,592 | SH | SOLE | 484,592 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 1,952 | 111,834 | SH | SOLE | 111,834 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 4,985 | 126,000 | SH | SOLE | 126,000 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 303 | 5,800 | SH | Call | SOLE | 5,800 | 0 | 0 | |
LAKESHORE ACQUISITION I CORP | *W EXP 07/15/202 | G53521111 | 79 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
LAKESHORE ACQUISITION I CORP | ORDINARY SHARES | G53521103 | 1,966 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
LANTHEUS HLDGS INC | COM | 516544103 | 7,447 | 290,000 | SH | SOLE | 290,000 | 0 | 0 | ||
LIFEMD INC | COM | 53216B104 | 1,793 | 288,700 | SH | SOLE | 288,700 | 0 | 0 | ||
MEI PHARMA INC | COM NEW | 55279B202 | 5,045 | 1,828,066 | SH | SOLE | 1,828,066 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 3,025 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 3,398 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
MOTIVE CAPITAL CORP | SHS CL A | G6293A103 | 1,011 | 102,099 | SH | SOLE | 102,099 | 0 | 0 | ||
MYRIAD GENETICS INC | COM | 62855J104 | 5,102 | 158,000 | SH | SOLE | 158,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 5,071 | 45,500 | SH | SOLE | 45,500 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 5,935 | 51,000 | SH | SOLE | 51,000 | 0 | 0 | ||
NOCTURNE ACQUISITION CORP | ORDINARY SHARES | G6580S114 | 4,990 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
NOCTURNE ACQUISITION CORP | RIGHT 12/26/2025 | G6580S106 | 210 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 5,560 | 556,000 | SH | SOLE | 556,000 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 974 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ONCORUS INC | COM | 68236R103 | 1,794 | 192,054 | SH | SOLE | 192,054 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 2,410 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | ||
PORTAGE BIOTECH INC | COM | G7185A128 | 1,524 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
POSEIDA THERAPEUTICS INC | COM | 73730P108 | 235 | 32,238 | SH | SOLE | 32,238 | 0 | 0 | ||
PROFOUND MED CORP | COM NEW | 74319B502 | 3,440 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | ||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 1,046 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 6,131 | 346,000 | SH | SOLE | 346,000 | 0 | 0 | ||
RENOVACOR INC | *W EXP 99/99/999 | 75989E114 | 501 | 731,561 | SH | SOLE | 731,561 | 0 | 0 | ||
RENOVACOR INC | COM | 75989E106 | 3,519 | 388,845 | SH | SOLE | 388,845 | 0 | 0 | ||
REPRO MED SYS INC | COM | 759910102 | 2,719 | 954,055 | SH | SOLE | 954,055 | 0 | 0 | ||
RESERVOIR MEDIA INC | *W EXP 08/26/202 | 76119X113 | 99 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SARISSA CAPITAL ACQUISITN CO | *W EXP 10/23/202 | G7823W110 | 75 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
SARISSA CAPITAL ACQUISITN CO | CL A | G7823W102 | 2,219 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 371 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
STRYVE FOODS INC | CLASS A COM | 863685103 | 1,070 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 94 | 82,233 | SH | SOLE | 82,233 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 2,064 | 108,000 | SH | SOLE | 108,000 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 5,688 | 1,272,412 | SH | SOLE | 1,272,412 | 0 | 0 | ||
TAILWIND ACQUISITION CORP | COM CL A | 87403Q102 | 1,256 | 128,414 | SH | SOLE | 128,414 | 0 | 0 | ||
TCR2 THERAPEUTICS INC | COM | 87808K106 | 503 | 59,150 | SH | SOLE | 59,150 | 0 | 0 | ||
TRACON PHARMACEUTICALS INC | COM NEW | 89237H209 | 3,039 | 785,341 | SH | SOLE | 785,341 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 3,419 | 141,000 | SH | SOLE | 141,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 2,487 | 254,000 | SH | SOLE | 254,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 55 | 84,666 | SH | SOLE | 84,666 | 0 | 0 | ||
UPHEALTH INC | *W EXP 06/08/202 | 91532B119 | 5 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
VAREX IMAGING CORP | COM | 92214X106 | 4,456 | 158,000 | SH | SOLE | 158,000 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 6,939 | 2,253,000 | SH | SOLE | 2,253,000 | 0 | 0 | ||
VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 3,203 | 256,244 | SH | SOLE | 256,244 | 0 | 0 | ||
VINCERX PHARMA INC | COM NEW | 92731L106 | 1,740 | 107,625 | SH | SOLE | 107,625 | 0 | 0 | ||
VIQ SOLUTIONS INC | COM NEW | 91825V400 | 2,086 | 704,687 | SH | SOLE | 704,687 | 0 | 0 | ||
VIRPAX PHARMACEUTICALS INC | COM | 928251107 | 1,305 | 271,846 | SH | SOLE | 271,846 | 0 | 0 | ||
X4 PHARMACEUTICALS INC | COM | 98420X103 | 4,256 | 804,598 | SH | SOLE | 804,598 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 3,300 | 216,000 | SH | SOLE | 216,000 | 0 | 0 | ||
XTANT MED HLDGS INC | COM NEW | 98420P308 | 6,942 | 6,254,458 | SH | SOLE | 6,254,458 | 0 | 0 | ||
YUMANITY THERAPEUTICS INC | COM | 98872L102 | 2,023 | 196,000 | SH | SOLE | 196,000 | 0 | 0 |